With this method, picomole amounts of phenylalanine and tyrosine can be rapidly separated and directly measured by absorbance at 206 nm. As little as 25 zL of serum or plasma suffices. Plasma is deproteinized and 20 L of the supernate, representing 1.8 tL of plasma, is applied to a reversed-phase column and eluted isocratically with a solution containing methanol and H3P04, pH 2.4. The tyrosine and phenylalanine peaks appear at 6 and 10 mm, respectively.
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We used the method to measure phenylalanine in plasma from six children with phenylketonuria.
Spectrofluorometry of tyrosine (1) and phenylalanine (2) is widely used. Such methods require about 1 and 3 h, respectively, and results can be altered by the presence of contaminants that affect fluorescence (3) . When measurement of only these two amino acids is required, methods designed to quantitate all plasma amino acids by liquid chromatography (4) or "high-performance" liquid chromatography (HPLC) (5) are unnecessarily lengthy and sophisticated. A recent paper (6) rivatives. In this method a 100-L sample of plasma is used, and it involves derivatization of the amino acids after their separation on a heated column (55 #{176}C). The present report describes a simpler HPLC method, which permits direct measurement of plasma phenylalanine and tyrosine by absorbance at 206 nm and requires as little as 25 1zL of plasma or serum, an amount that can be obtained from the blood collected in one hematocrit tube from a finger prick. The molar absorptivities of phenylalanine and tyrosine at 206 nm are similar, assuring the same sensitivity of measurement of these amino acids.
Materials and Methods
Separations were made at ambient temperature on a 5-jm Ultrasphere ODS column (250 X 4.6 mm, i.d.), fitted with a guard column (42 X 3.2 mm, i.d.) with 10-nm ODS packing (all from Beckman Instruments, Inc., Fullerton, CA 92634). Plasma was prepared from blood collected in siliconized tubes pretreated with potassium EDTA or in heparmnized capillary hematocrit tubes. The blood was centrifuged promptly at room temperature, and the plasma removed and kept on ice or stored at -20 #{176}C until prepared for analysis. Blood from patients with phenylketonuria (PKU) was collected in hematocrit tubes and mailed to the laboratory, where the serum was separated by centrifugation. Wedeproteinized serum or plasma by an adaptation of an earlier method (7) . A measured volume of serum or plasma and 9 volumes of 1.11 mol/L HC1O4 were mixed well in a capped 2-mL polystyrene autoanalysis cup (Fisher). After 10 mm the suspension was centrifuged for 6 mm in a clinical centrifuge. A measured aliquot of the supernate (usually about 0.8 of the total volume) was transferred to a second cup, treated with 0.091 volume of 10 mol/L KOH, capped, set on ice for 10 mm, and then centrifuged for 6 mm to sediment KC1O4. About 35 ILL of the supernate, the pH of which should be <7, was used to flush and fill the 20-ILL sample loop for injection onto the column. All samples were run in duplicate. Any KCIO4 that later precipitated in the samples settled readily to the bottom of the tube and could be avoided in sampling.
Ultrafiltration of the supernate to remove any residual protein prolongs the life of the guard column. For this purpose we used an MF-1 microfilter (BioAnalytical Systems, Inc., West Lafayette, IN 47906), equipped with a filter punched with a cork borer from a Diaflo YM 5 ultrafilter (Amicon Corp., Lexington, MA 02173). Filtration was effected in a clinical centrifuge. The chromatogram, as exemplified below in Figure 1B ILL. To test agreement between our method and conventional analysis for amino acids (4), I deprotemnized a single sample of plasma from blood collected, in a tube pretreated with potassium EDTA, at 1020 hours from a normal volunteer who had breakfasted at 0900 hours. Aliquots of this sample, analyzed by both methods, gave values of 48.7 and 48. 6 ) and 102.8% (SEM 0.5) of the calculated values for added tyrosine and phenylalanmne, respectively-within the experimental error of the procedures. I find no difference in the concentrations of phenylalanine and tyrosine in serum and in plasma prepared from the same sample of normal blood. The plasma was obtained from blood collected in a siliconized tube pretreated with potassium EDTA.
Results
Hemolysis leads to higher values for both amino acids. I find that values (ILmol/L) for tyrosine are 52% higher and for phenylalanine are 13% higher when whole blood (hematocrit, 41%) is analyzed, as compared with values obtained for plasma prepared from the same sample of blood from a normal volunteer.
The present method can potentially permit measurement of plasma tryptophan, which elutes at 22 mm ( Figure 1B) . However, we have not taken steps to protect our samples from light to prevent loss of tryptophan due to its photolability (10) . Tryptophan also binds to serum albumin (11) . I assessed this These problems of photosensitivity and binding by serum albumin of plasma tryptophan were not addressed by Neckers et al. (6) . Table 1 permits comparison of values obtained for serum of children with PKU by the present method and by fluorescence measurements (2) . The children, ages 3 to 13 years, are being monitored for dietary control of plasma phenylalanine.
At 7 mm after injection of a sample onto the column the sensitivity of the detector was decreased to 0.05 A full scale or less, to permit measurement of the phenylalanine peak. An advantage of the HPLC method is that data on concentrations of both tyrosine and phenylalanine in plasma are available from a single analysis. Plasma tyrosine values are low in the last two patients, who might benefit from supplements of this amino acid, which is a dietary essential for individuals with PKU.
I am satisfied that, in this method, any interfering coelution of plasma constituents or drugs should be evidenced by alterations in the sharp peaks attributed to tyrosine and phenylalanine in Figure 1 . Table 2 shows the retention times of some molecules that are structurally similar to tyrosine and phenylalanine but differ considerably from them in elution behavior. This illustrates the excellent resolving power of the method. I tested 275 pmol of the common aromatic drug, acetylsalicylic acid (aspirin), and found no measurable absorbance during a 24-mm analysis by this HPLC method, with 22 mL of methanol per deciliter of the eluting solvent.
I find that a-methyl phenylalanine is useful as an internal standard. At 0.01 A full scale, the sensitivity of measurement is 3.6 pmol per millimeter of peak height.
Discussion
Of the methods currently used for quantitative measurements of amino acids in plasma, only amino acid analysis, an HPLC method that requires post-column derivatization of the amino acids with o-phthaldialdehyde at 55 #{176}C (6) , and the present method yield values for both phenylalanine and tyrosine in the same analysis. The present method is the simplest of the three. A single-pump HPLC system, run at a constant rate of flow of a single solvent, and an ultraviolet detector with a wavelength setting of 206 nm suffice for the analysis of a 20-ILL sample (representing 1.8 ILL of plasma or serum) every 22 mm.
We find the present method potentially applicable to the study of several clinical problems: (a) accurate assessment of the degree and, through simultaneous measurement of plasma tyrosine, insight into the cause of neonatal hyperphenylalaninemia (12) , and (b) quantitative analysis of plasma phenylalanine and tyrosine for guidance in the dietary control of plasma phenylalanine in patients with PKU. In addition, examination of the phenylalanmne/tyrosmne ratio in plasma may prove helpful in determining the severity of liver disease (13) and in identifying individuals who are carriers of the PKU gene (14) . We have noted an increase in the ratio of plasma phenylalanine to tyrosine 24 h after infusion of high-dose methotrexate (15) and have suggested that measurement of this ratio provides a means of monitoring intracellular methotrexate in the liver following this form of chemotherapy. We are hopeful that the HPLC method herein described will prove useful in these and related investigations. 
